The global drug screening market was valued at USD 3.83 Billion in 2019 and is projected to reach USD 13.56 Billion by 2027, at a CAGR of 17.1% during the forecast period. Upsurge in consumption of illegal substances and alcohol and implementation of stringent regulations in developing as well as developed regions are propelling the drug screening market. The drug screening process has become quite common at airports and railway stations to ensure the safety of the local population.
The latest study on the Drug Screening Market includes a detailed analysis of the future trends and demands for the forecast period, 2020 - 2027. The market intelligence report on the Drug Screening Market encompasses an in-depth evaluation of different products, applications, end-users and their sales across different regions. A closer look at the important industry terms and definition, technology advancements and forces influencing the product and production capability further makes the report a valuable reference material.
Read more@ https://www.emergenresearch.com/industry-report/drug-screening-market
Competitive Landscape
Quest Diagnostics
LabCorp
Drägerwerk
Thermo Fisher Scientific
Alfa Scientific Designs
Omega Laboratories
Roche Diagnostics Limited
Siemens Healthineers
Premier Biotech
Psychemedics
You Can Download Free Sample PDF Copy of Drug Screening Market at https://www.emergenresearch.com/request-sample/442
Regional Landscape
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
Facebook | LinkedIn | Twitter | Blogs
Global Medical Billing Outsourcing Market is anticipated to reach USD 16.9 billion by 2024 due to the rising technological innovation in healthcare services.
It improves the cash collection and flows to reduce the cost and labor problems.
Medical billing outsourcing saves high software costs and equipment due to rapid technological advancements.
It focuses on improved patient care instead of billing.Medical billing outsourcing market is majorly driven by the rise in geriatric population worldwide that demands efficient healthcare services.
This is attributed to the developed economies that comprises higher percentage of elderly population.
Currently, the market is witnessing high growth in adoption of outsourcing services by the physicians and hospitals.Medical billing outsourcing industry is categorized on the basis of services, component, end user and geography.
Preimplantation Genetic Diagnosis Market:WiseGuyReports.com adds “Global Preimplantation Genetic Diagnosis Market Research Report 2020 Analysis and Forecast 2026” reports to its database.Executive SummaryGlobal Preimplantation Genetic Diagnosis Market is valued approximately USD 407.04 Million in 2019 and is anticipated to grow with a healthy growth rate of more than 10% over the forecast period 2019-2026.
The testing is done when one or both genetic parents has a known genetic abnormality.
Therefore, such test is performed on embryo to identify or determine any genetic abnormality or disorders.
Due to such favorable offering of preimplantation genetic diagnosis people across the globe are adopting such tests, hence increasing awareness among people regarding preimplantation genetic diagnosis coupled with rising incidence of newborn baby with genetic disorders across the globe drives the growth of market over the forecast years.
In Addition, rising number of fertility clinics worldwide are the factors driving the growth of market over the upcoming years.
However, high Procedural cost associated with preimplantation genetic testing is the factor hampers the growth of market.Request Free Sample Report @ https://www.wiseguyreports.com/sample-request/5278138-global-preimplantation-genetic-diagnosis-market-size-study-byThe regional analysis of global Preimplantation Genetic Diagnosis market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World.
Mar 01, 2021: Global Medical Billing Outsourcing Market is anticipated to reach USD 16.9 billion by 2024 due to the rising technological innovation in healthcare services.
Medical billing outsourcing is a business process adopted by hospitals, nursing homes and healthcare providers to acquire healthcare related services via outsourcing.
It focuses on improved patient care instead of billing.Medical billing outsourcing market is majorly driven by the rise in geriatric population worldwide that demands efficient healthcare services.
This is attributed to the developed economies that comprises higher percentage of elderly population.
Currently, the market is witnessing high growth in adoption of outsourcing services by the physicians and hospitals.Medical billing outsourcing industry is categorized on the basis of services, component, end user and geography.
On the basis of services, the market is divided into front end, middle and backend.
According to the new market research report “Esoteric Testing Market by Type (Infectious Disease, Endocrinology, Oncology, Toxicology, Immunology, Genetic Testing), Technology (MS, CLIA, ELISA, PCR), End User (Independent & Reference Laboratories, Hospital Laboratories) – Global Forecast to 2026″, published by MarketsandMarkets™, the global market is projected to reach USD 36.3 billion by 2026 from USD 21.0 billion in 2021, at a CAGR of 11.6% during the forecast period.Browse and in-depth TOC on “Esoteric Testing Market”134 – Tables47 – Figures244 – PagesDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=76794708The rising incidence of chronic and infectious diseases, increasing use of esoteric DNA sequencing technologies in precision medicine, early diagnosis of cancer, and advancements in the personalized medicine are the major factors driving the growth of the market.In 2020, infectious diseases accounted for the largest share of the Esoteric Testing Market.
The genetic testing segment is expected to grow at the highest CAGR during the forecast period.Based on the type, the market is segmented into infectious disease testing, endocrinology testing, oncology testing, genetic testing, toxicology testing, immunology testing, neurology testing, and other testing.
In 2020, the infectious disease testing segment accounted the largest share of the Esoteric Testing Market.
The largest share of the segment is attributed to the increasing incidence of infectious diseases, technological innovations in molecular diagnostics, and improving healthcare infrastructure in developing nations.
The genetic testing segment is expected to register the highest CAGR during the forecast period.
The fastest growth of the genetic testing segment is attributed to the advancements in the sequencing technologies such as NGS and increasing awareness.CLIA segment account for the largest share of the market in 2020.Based on technology, Esoteric Testing Market is segmented into chemiluminescence immunoassay (CLIA), enzyme-linked immunosorbent assay (ELISA), mass spectrometry, real-time PCR, flow cytometry, DNA sequencing, and other technologies.
It includes the size, share, growth, trends, key players, segments and regional analysis in detail during the study year 2020-2027.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the clinical laboratory services market include Qiagen, OPKO Health, Inc., Abbott, Cinven, Sonic Healthcare, NeoGenomics Laboratories, Inc., Arup Laboratories, Fresenius Medical Care, Viapath Group LLP, Almac Group, Quest Diagnostics, Inc., Laboratory Corporation of America Holdings (LabCorp), Charles River Laboratories International, Inc., DaVita, Inc., Siemens Healthcare GmbH, and SGS SA.
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Clinical Laboratory Services Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/clinical-laboratory-services-market/download-sampleMarket DynamicsThe rising prevalence of target diseases together with increasing demand for early disease diagnostic tests are the major factor driving the Clinical laboratory services market.
The constant technological advancements in the area of clinical testing and the introduction of home health tests and novel solutions are contributing to the high market growth.
The rising public-private investments and research funding & grants to build up innovative laboratory testing procedures are positively impacting the clinical laboratory services market's growth.
Moreover, the growing adoption of digital pathology platforms and increasing preference for comprehensive health checkups offered by clinical laboratories are likely to create lucrative growth opportunities for key players of the Clinical laboratory services market in the coming years.The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis.
Mar 12, 2020: The global Pre Painted Metal market size is expected to reach USD 27.9 billion by 2025, expanding at a CAGR of 11.2%, according to a new report by Radiant Insights, Inc. Growth in the commercial construction sector is likely to propel the product demand as it is used in facades, cladding system, and roofing structures.Pre-painted metal products such as sheets, plates, and coils are largely used in the commercial construction industry.
The product offers superior properties such as corrosion, wear, UV resistance, no environmental pollution, and durability, which resulted in the greater penetration of pre-painted products for aforementioned building applications.To Request A Sample Copy Of This Report @: https://www.radiantinsights.com/research/pre-painted-metal-market/request-sampleSimilarly, the product is used in manufacturing various automotive components such as oil filter caps, wiper blade assemblies, and body-in-white of cars.
North America is the fastest growing segment in terms of volume owing to growth in construction and automotive sectors, especially in U.S.
Also, increasing production of motor and electric vehicles is anticipated to drive the market over the coming years.The pre-painted metal market is fragmented in nature with the presence of established and local players such as ArcelorMittal, Tata BlueScope Steel, SSAB, Nippon Steel Corporation, American Douglas Metals, Inc., NLMK, Voestalpine AG, MMK, and Shandong Kerui Steel Plate Co., Ltd.
Rapid urbanization and growing population are likely to promote the growth of residential and commercial sectorsTransportation is the one of the fast growing segments with a CAGR of 11.7% in terms of revenue over the coming years.
Business Environment Analysis: Pre-Painted Metal Market3.6.1.
